Bolivia vs South Africa: Antiretroviral therapy coverage for PMTCT
Bolivia
98.0%
in 2023
South Africa
98.0%
in 2024
Bolivia rank
9th
South Africa rank
9th
Antiretroviral therapy coverage for PMTCT over time
- Bolivia
- South Africa
How they compare
Bolivia currently reports 98.0% against 98.0% in South Africa, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was South Africa ahead.
Bolivia ranks 9th and South Africa ranks 9th of 84 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.9% | 28.3% | 24.4% | South Africa |
| 2010s | 56.9% | 96.3% | 39.4% | South Africa |
| 2020s | 88.5% | 96.5% | 8.0% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Bolivia or South Africa?
- Bolivia, at 98.0% against 98.0% in South Africa as of 2023.
- What is the difference in antiretroviral therapy coverage for pmtct between Bolivia and South Africa?
- 0.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and South Africa?
- 24 years are reported by both, from 2000 to 2023.
- How do Bolivia and South Africa rank globally for antiretroviral therapy coverage for pmtct?
- Bolivia ranks 9th and South Africa ranks 9th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).